Retrospective Analysis of Serum Parameters in Patients Treated With Check-Point Inhibitors in 2AND Line for Advance Non-small-Cell Lung Cancer

被引：0
|
作者：
Paco, Pablo Flores [1 ,2 ]
Moreno, Alberto [1 ,2 ]
Barneto, Isidoro [1 ,2 ]
Sanchez, Pedro [1 ,2 ]
Vargas, Alicia [1 ,2 ]
Guevara, Geraldina [1 ,2 ]
Lopez-Herrero, Maria [1 ,2 ]
Aranda, Enrique [1 ,2 ]
机构：
[1] Univ Reina Sofia, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba, Cordoba, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.43
引用
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [21] Retrospective Analysis of Third-Line and Fourth-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
    Asahina, Hajime
    Sekine, Ikuo
    Horinouchi, Hidehito
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kubota, Kaoru
    Tamura, Tomohide
    CLINICAL LUNG CANCER, 2012, 13 (01) : 39 - 43
  • [22] Non-small-cell lung cancer (NSCLC) treated with chemotherapy: Survival analysis of 50 patients
    Flores, MM
    Murillo, SM
    Alonso, EG
    Gilart, AB
    CarcellerVidal, JA
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1088 - 1088
  • [23] Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis
    Zhang, Lei
    Wang, Hong
    Tian, Jizheng
    Sui, Lili
    Chen, Xiaoyan
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [24] Gefitinib Monotherapy in Advanced non-small-cell Lung Cancer: A Retrospective Analysis
    Shrestha, S.
    Joshi, P.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (02) : 66 - 71
  • [25] Practical management of patients with non-small-cell lung cancer treated with gefitinib
    Shah, NT
    Kris, MG
    Pao, W
    Tyson, LB
    Pizzo, BM
    Heinemann, MH
    Ben-Porat, L
    Sachs, DL
    Heelan, RT
    Miller, VA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 165 - 174
  • [26] Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib
    McGrath, Alexandria C.
    Sandhu, Geeta
    Walpole, Euan
    McCaffrey, Elizabeth
    Hollingworth, Samantha A.
    ANTI-CANCER DRUGS, 2018, 29 (08) : 786 - 790
  • [27] Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
    Park, Hyung Soon
    Lim, Sun Min
    Shin, Ho Jung
    Cho, Arthur
    Shin, Jae-Gook
    Lee, Min Goo
    Kim, Hye Ryun
    Kim, Joo Hang
    Cho, Byoung Chul
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (03): : 116 - 125
  • [28] Surgical outcomes and prognosis of non-small-cell lung cancer in patients with chronic lung diseases: a retrospective analysis
    Choi, Soohwan
    Park, Jaekil
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (02) : 357 - 364
  • [29] Effect of Amrubicin in Patients with Previously Treated Non-Small-Cell Lung Cancer
    Takayama, S.
    Tamura, T.
    Kawajiri, T.
    Nishi, T.
    Kudo, K.
    Kuyama, S.
    Kawakado, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S937 - S937
  • [30] Carboplatin and paclitaxel for previously treated patients with non-small-cell lung cancer
    Roa, V
    Conner, A
    Mitchell, RB
    CANCER INVESTIGATION, 1998, 16 (06) : 381 - 384
12345